Clinical Trial Results:
Etude de preuve de concept de phase IIB, multicentrique, en double aveugle, randomisée, contrôlée versus placebo, évaluant le diltiazem en association avec le traitement standard dans la prise en charge de patients hospitalisés pour pneumopathie à COVID-19
Summary
|
|
EudraCT number |
2021-004160-94 |
Trial protocol |
FR |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jan 2025
|
First version publication date |
08 Jan 2025
|
Other versions |
|
Summary report(s) |
fin |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.